All Type of News
For past 5 years, domestic companies suffer while multinational ones cruise
Domestic pharmaceutical companies were known to record slow performances in EDI for the past 5 years.
On the other hand, multinational pharmaceutical companies generally had high performances; for example, Pfizer kep...
MOHW, “Implementation of drug dispensers will not change basis of pharmacists’ system”The Ministry of Health and Welfare revealed an opinion to continue installation of video telemedicine dispensers since it expects the installation will not influence the basis o...
|
Chong Kun Dang gears up on first generic of ‘Revlimid’ recording KRW 7 trillionChong Kun Dang was approved to conduct bioequivalent tests for approval of the first generic of ‘Revlimid(generic name: lenalidomide, Celgene),’ a multiple myeloma therapy whose...
|
Sales licenses of Agrylin & Effient transferred to respective Shire & Daiichi Sankyo
In the 2nd half of the year, selling companies of the essential thrombocytosis therapy, ‘Agrylin’ and the antithrombotic therapy, ‘Effient,’ will be changed.
So far, Agrylin and Effient were sold by Yuhan Corporation...
Radiology doctors file civil suits against Siemens
Doctors who opened radiological hospitals and clinics are preparing for a lawsuit against Siemens, a global medical device company.
When selling CTs and MRIs to domestic hospitals and clinics so far, Siemens has inse...
While 1st opposition party push forwards with alteration, MOHW remains unshakable
As soon as the 20th National Assembly was opened, the 1st opposition party is trying to carry out the reformation of the National Health Insurance imposing system as a health & medical pledge, but the competent minist...
Last year’s pharmaceutical exports record USD 2.95 billion increased by 22%
The last year’s pharmaceutical manufacturing performance was increased by 3.4% to KRW 16.9699 trillion compared with the year of 2014. Moreover, the pharmaceutical exports and imports were recorded USD 2.95 billion an...
Hanmi’s 4 products including ‘Amosartan 5/50mg’ manufactured worth of KRW 67.2 billionThe last year’s total manufactured amount of products which were approved as an incrementally modified drug was KRW 184.2 billion, and the Hanmi Pharm’s 4 products including ‘Am...
|
“Who’s Young-ran Kim?” Act known by big pharmas’ headquarters
Not long ago, an officer from a multinational pharmaceutical company’s headquarters asked a question to a reporter.
“Who’s Young-ran Kim?”
The ‘Anti-Corruption and Bribery Prohibition Act’ which will be enforced on ...
Cialis generics expect sales increase with prostate enlargement indication
With the original, Cialis generics will soon be available for the use of benign prostatic hyperplasia treatment.
As the post-marketing surveillance on the Cialis 5mg’s positive benign prostatic hyperplasia indicatio...
